LAG3 and skin disorder: Findings of Wang et. al indicated one additional case of dermatitis upon increasing the dose of LAG‐3 inhibitor from 0.5 to 2 mg (mg); however, due to the limited sample size (n = 11), it is difficult to draw any conclusions.10